New York   |   May 15-16, 2014
Medical and Social Determinants of Cardiometabolic Health

PROGRAM AT A GLANCE

DAY 1: THURSDAY, MAY 15, 2014
6:30 AM Registration OPENS
8:00 AM – 9:30 AM
OPENING CEREMONY/NEIL SHULMAN SYMPOSIUM
CME: 1.5/CEU: .15
WelcomeConference Co-ChairGbenga O. Ogedegbe, MD, MPH
Conference OverviewConference Co-ChairC. Alicia Georges, EdD, RN
Introduction and Acknowledgement of ISHIB FoundersImmediate Past PresidentDavid S. Kountz, MD
KEYNOTE PRESENTATION: Hypertension Treatment and Control: Translational Science Insights and the Future of Implementation ResearchKeynote SpeakerGeorge A. Mensah, MD
George A. Mensah, MD is internationally renowned for his scientific leadership and expertise in the fields of cardiovascular medicine, health disparities research, and global health. As Director of Center for Translation Research and Implementation Science (CTRIS), he works with leadership and staff at NIH to advance late stage translation research and implementation science to maximize the population health impact of our research discoveries in heart, lung, and blood diseases.
ConclusionConference Co-ChairGbenga O. Ogedegbe, MD, MPH
9:45 AM – 11:15 AM
PLENARY SESSION I:
Lipid Management in Racial and Ethnic Minorites: Are the 2013 Cholesterol Guidelines Sufficient?
Upon completion of this session, participants should be able to:
  • Understand the rationale behind development of the 2013 cholesterol guidelines
  • Describe major changes to the 2013 cholesterol guidelines compared to previous guidelines
  • Understand the importance of the guidelines in optimizing cardiovascular outcomes in racial and ethnic minoritiess
  • Understand how to utilize the guidelines to assess cardiovascular risk in racial and ethnic minorities
  • IntroductionChairJames Underberg, MD, MS
    Lipid Management in Racial and Ethnic Minorities: Are the 2013 Cholesterol Guidelines Sufficient for the Hispanic PopulationSpeakerJoaquin Carral Gomez, MD
    Lipid Management in Racial and Ethnic Minorities From a Women’s Health Perspective: Are the 2013 Cholesterol Guidelines Sufficient?SpeakerMerle Myerson, MD
    ConclusionChairJames Underberg, MD, MS
    1:00 PM – 2:30 PM
    PLENARY SESSION II:
    2014 Hypertension Guidelines and the ISHIB Consensus Statement: Attaining Healthy People 2020 Control Goals in Diverse Practice Settings
    CME: 1.5/CEU: .15
    Upon completion of this session, participants should be able to:
  • Understand the rationale behind the development of JNC 8 and the ISHIB Consensus Statement
  • Understand the roles of scientific evidence and expert opinion in development of JNC 8 and the ISHIB Consensus Statement
  • IntroductionChairGbenga O. Ogedegbe, MD, MPH
    JNC 8 - Implications for Diverse Populations SpeakerJackson T. Wright, Jr., MD, PhD
    Upon completion of this session, participants should be able to:
  • Understand how to interpret the guidelines and apply to a diverse patient population
  • Prescribe and optimize an effective management strategy to achieve blood pressure treatment goals
  • Practical Tools for Improving Medication AdherenceSpeakerHayden Bosworth, PhD
    Upon completion of this session, participants should be able to:
  • Understand variables in prescribing medications that impact adherence, e.g., number of chronic diseases and medications, role of single-pill combinations
  • Understand patient and system factors that impact adherence and strategies for reducing barriers, engaging patients, and enhancing adherence
  • ConclusionChairGbenga O. Ogedegbe, MD, MPH
    2:30 PM – 3:30 PM
    EXHIBIT AND ABSTRACT POSTER SESSION
    3:30 PM – 5:30 PM
    HYPERTENSION ACADEMY
    CME: 2.0/CEU: .2
    Upon completion of this session, participants should be able to:
  • To understand the data from prospective supplementation trials of vitamin D in Vitamin D deficient African American hypertensives
  • To understand the policy and therapeutic implications of Mendelian randomized trials for hypertension treatment strategies
  • To understand the role of secondary causes of hypertension in difficult to control hypertensives
  • To give guidance as to which therapies will likely be approved for general or restricted use
  • Introduction and OverviewChairJohn M. Flack, MD, MPH
    Benefits of Long-term Levels of Low Blood Pressure: Lessons Learned from Mendelian Randomized TrialsSpeakerBrian A. Ference, MD, MPhil, MSc
    Upon completion of this topic, participants should be able to:
  • To understand the concept of natural Mendelian randomized trials
  • To understand the epidemiological risk estimates over the long-term from Mendelian randomized trials of blood pressure
  • Effective Strategies for Obtaining Blood Pressure Control in Difficult PatientsSpeakerAngela L. Brown, MD
    Upon completion of this topic, participants should be able to:
  • To understand the basic principles of combination antihypertensive drug therapy as well as uncommon but effective combination strategies (e.g, dual calcium channel blockade)
  • To understand optimal strategies for the use of diuretics in complex antihypertensive drug regimens, including the use of multiple diuretics simultaneously
  • Rationale for Vitamin D Supplementation as a BP Lowering Strategy in African AmericansSpeakerJohn M. Flack, MD, MPH
    Upon completion of this topic, participants should be able to:
  • To understand the excessively high prevalence of vitamin D deficiency in African Americans
  • To understand the epidemiological correlations of vitamin D deficiency with hypertension
  • To understand the physiological rationale for vitamin D deficiency contributing to BP elevations
  • The Next Frontiers in Hypertension TherapeuticsSpeakerDomenic A. Sica, MD, PhD
    Upon completion of this topic, participants should be able to:
  • To provide an overview of device-based antihypertensive therapies
  • To understand the new pharmacological therapies under development for hypertension
  • ConclusionChairJohn M. Flack, MD, MPH
    5:30 PM – 6:30 PM
    PRESIDENT’S RECEPTION AND AWARD CEREMONY
    TOTAL DAY 1 CME: 6.5/CEU: .65
    DAY 2: FRIDAY, MAY 16, 2014
    7:30 AM Registration Location:
    8:00 AM – 5:00 PM Speaker Ready Room Location:
    7:00 AM - 9:00 AM
    PLENARY SESSION III:
    The Diabesity Epidemic: What Will it Take to Reverse Trends and Attain Health Equity
    CME: 2.0/CEU: .2
    Upon completion of this session, participants should be able to:
  • Discuss the magnitude of obesity and type 2 diabetes in African Americans
  • Explain the effective strategies in management of obesity and type 2 diabetes in African Americans
  • Describe the impediments to prevention of obesity in African Americans
  • IntroductionCo-Chairs Kwame Osei, MD
    IntroductionCo-Chairs Rita J. Louard, MD
    Global Perspective of Diabesity: Relevance to Blacks in African DiasporaSpeakerKwame Osei, MD
    Upon completion of this session, participants should be able to:
  • Discuss the global pandemic of diabetes and obesity
  • Discuss geographic impact of diabetes and obesity in blacks in the African Diaspora
  • Discuss the emerging pathobiology of diabetes and its prevention in blacks in the African Diaspora
  • Limitations and Impediments of Current Approaches to Reverse Diabesity in African AmericansSpeaker James R. Gavin, III, MD, PhD
    Upon completion of this session, participants should be able to:
  • Understand the impediments to prevention of diabetes in African Americans
  • Determine effective strategies to overcome the challenges required to reverse the trend of the number of racial and ethnic minorities with diabetes and obesity
  • Lessons from DPP and LookAhead: Implications for African AmericansSpeakerAnthony Cannon, MD
    Upon completion of this session, participants should be able to:
  • Understand the benefits of lifestyle modifications in preventing diabetes in racial and ethnic minorities
  • Discuss and effectively utilize strategies for sustaining lifestyle modifications to prevent diabetes
  • ConclusionChair James W. Reed, MD
    9:00 AM – 10:30 AM
    EXHIBIT AND ABSTRACT POSTER SESSION
    10:30 AM – 12:00 PM
    WORKSHOP A:
    Utilizing the Practical Tools
    CME: 1.5/CEU: .15
    IntroductionCo-ChairsKwame Osei, MD
      IntroductionCo-ChairsWallace R. Johnson, Jr., MD
    ISHIB DOC Program Community Implementation: Lessons LearnedSpeakerTrudy Gaillard, PhD, RN, MS, CDE
    Upon completion of this session, participants should be able to:
  • Review barriers and challenges toward implementing community-based programs for African Americans
  • Discuss ways to improve community involvement in diabetes education and management programs
  •   CVD ToolKit: Principles and ResultsSpeaker Wallace R. Johnson, Jr, MD
    Upon completion of this session, participants should be able to:
  • Understand the guiding principles and rationale for development of the CVD Toolkit
  • Discuss the results of the CVD Toolkit implementation study
  • Understand how to use the CVD Toolkit in the practice setting to improve provider management of hypertension
  • CVD ToolKit: Community Implementation and IMPACT APPSpeakerDavid S. Kountz, MD
    David S. Kountz, MD is Vice President, Academic Affairs, Jersey Shore University Medical Center (JSUMC), and Professor of Medicine and Associate Dean, Rutgers Robert Wood Johnson Medical School (RWJMS). Dr. Kountz is responsible for non-nursing academic programs at the hospital, including continuing medical education, graduate medical education and the clinical research enterprise for Meridian Health. Dr. Kountz also serves as liaison with RWJMS to advance JSUMC from major affiliate to designation as a Regional Medical Campus.
    Upon completion of this session, participants should be able to:
  • Describe the rationale for developing the ISHIB CVD electronic application in the community-based practice setting
  • Understand how to utilize the ISHIB CVD electronic application to educate and empower minority patients to become more involved in self-care to improve outcomes
  • ConclusionChair Kwame Osei, MD
    5:00 PM – 6:30 PM
    ASH-ISHIB JOINT SESSION:
    Social Determinants Of Health And Health Equity: From Understanding To Action
    NOTE: ASH will be provided CME/CEUs for this session
    CME: 1.5/CEU: .5
    Upon completion of this session, participants should be able to:
  • Examine the contributions of neighborhood characteristics, low socioeconomic status and racism to increased levels of risk factors and hypertension, poor blood pressure control and cardiovascular outcomes in low income and minority populations
  • Welcome and Opening RemarksChairDavid S. Kountz, MD
    Critical Role of Geography in Health Disparities: Opportunities with Healthcare ReformSpeakerGary A. Puckrein, PhD
    Upon completion of this session, participants should be able to:
  • Understand that racial and ethnic disparities are concentrated in limited geographic areas
  • Understand how to use geographic data to develop targeted strategies aimed at improving outcomes and reducing health disparities
  • 5:25 PM – 5:45 PM The U.S. Healthcare Safety Net and Cardiometabolic Health Equity. Progress and PlansSpeakerJonathan N. Tobin, PhD
    Jonathan N. Tobin, Ph.D., is President/CEO of Clinical Directors Network (CDN). Dr. Tobin is a Professor of Epidemiology & Population Health at Albert Einstein College of Medicine, and Co-Director for Community-Engaged Research at Rockefeller University. He has served as Principal/Co-Principal Investigator on NIH, SAMHSA, EPA, PCORI, CDC, AHRQ and HRSA grants.
    Upon completion of this topic, participants should be able to:
  • Examine the interaction of neighborhood, clinical practice and patient-level factors in blood pressure control/cardiovascular risk factor management.
  • Discuss challenges and limitations associated with purely clinical efforts to control high blood pressure in low income and racially diverse communities.
  • Identify the role Federally Qualified Health Centers (FQHCS) and practice-based research networks (PBRNS), such as Clinical Directors Network (CDN), can play in increasing the self-management and control of blood pressure and cardio-metabolic risk.
  •   The National Institute for Minority Health and Health Disparities: History and Future Directions in The Quest for Health EquitySpeakerTBA
    Panel DiscussionChair/ ModeratorKeith C. Ferdinand, MD
    Summary and Closing RemarksCo-ChairKeith C. Ferdinand, MD
    TOTAL DAY 2 CME: 3.5/CEU .35
    TOTAL CME: 10.0/CEU 1.0
    DAY 2: SATURDAY, MAY 17, 2014
    1:00 PM – 4:00 PM BOARD OF TRUSTEE MEETING (CLOSED SESSION)PresidentBrent M. Egan, MD